High-content genome-wide RNAi screen of the Parkin dependent elimination of depolarized mitochondria
High-content genome-wide RNAi screen of the Parkin dependent elimination of depolarized mitochondria
批准号:
288418809
负责人:
Dr. Sven Geisler
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The aim of this proposal is to find and to investigate new modulators which are involved in the PINK1/Parkin dependent elimination of depolarized mitochondria, termed mitophagy. The causes of sporadic Parkinsons disease are largely unknown. However, on the basis of rare monogenetic forms of the disease one try to gain insight into the molecular disease progression of Parkinsons Disease. For example in patients with mutations and failure of the monogenetic recessive gene products PINK1 and Parkin, a severe deregulation of the mitochondrial homeostasis was observed. It is expected, that such malfunctioned mitochondria may contribute to the death of neurons. Thus, it is crucial for the cell to possess a precise mechanism to identify dysfunctional mitochondria, targeting them for degradation and hence maintain a healthy mitochondrial network. The failure of mitochondrial function can be simulated in a cell culture model via uncoupling the mitochondrial membrane potential using the protonophore CCCP. This starts a PINK1 and Parkin dependent cascade to remove dysfunctional mitochondria. PINK1 and Parkin are stabilized on the outer mitochondrial membrane of mitochondria with low membrane potential which leads to attachment of ubiquitin on these organelles. This serves as signal for the autophagic machinery to finally eliminate the dysfunctional organelles within the lysosomes. In an established HeLa cell model of mitochondrial depolarization and mitophagy the 2h (Parkin translocation) and 24h (mitophagy) time point of CCCP treatment were frequently investigated. In the last years several whole genome siRNA based high-content imaging screens revealed numerous new regulatory proteins of Parkin translocation. Thus, the knowledge of the molecular processes early in mitophagy could be greatly extended. However, the other interesting time point is the complete elimination of mitochondria after 24 hours of depolarization. To our knowledge, a screen in human cells of this time point using a siRNA based whole genome library or a sub-library was not performed up to date. We will establish such a screen for the final step of mitophagy and we will identify new regulatory proteins. Then the molecular function(s) of promising modulators will be characterized. Here, we will determine the exact function, the localization, the interactions and the activity in the mitophagy model using different methods. We try to regulate these functions with different inhibitors or stimulators to restore the removal of dysfunctional mitochondria. Thus, we expect a more refined view on the whole process of mitophagy and a new layer of candidate proteins in the process of mitophagy would emerge.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
雷特综合症致病蛋白MeCP2在DNA损伤修复中的功能及分子机制研究
-
批准号:32070780
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:刘红美
-
依托单位:
组蛋白去乙酰化酶SirT7翻译后修饰及其在调控肿瘤耐药中的作用研究
-
批准号:32070770
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:孙莲慧
-
依托单位:
新的FANCM关联蛋白复合物FMAP150-FMAP160调控FANCM修复停滞复制叉的作用及机制
-
批准号:32070716
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:ZHIJIANG YAN
-
依托单位:
激活SENP1-Sirt3轴改善线粒体健康对延缓衰老的作用与机制研究
-
批准号:92049113
-
项目类别:重大研究计划
-
资助金额:60.0万元
-
批准年份:2020
-
负责人:王田实
-
依托单位:
小鼠Pold4介导的基因组稳定性在肺癌发生发展中的功能和机制研究
-
批准号:31900512
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:周忠诚
-
依托单位:
DNA损伤诱导的KIFC1磷酸化介导肿瘤耐药和复发的机制及策略研究
-
批准号:31970720
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:范广建
-
依托单位:
果蝇新基因dNKAP调控R-loop水平和基因组稳定性的分子机制及其在肿瘤发生中的功能研究
-
批准号:31970668
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:戈万忠
-
依托单位:
KLF14翻译后修饰及其在调控肿瘤细胞死亡中的作用研究
-
批准号:31970736
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:王传贵
-
依托单位:
XPF蛋白的乙酰化修饰在DNA损伤修复中的功能与作用机制研究
-
批准号:31970664
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:刘婷
-
依托单位:
有丝分裂检查点激酶对遗传稳定性的维持及其在癌症中的失调
-
批准号:31871361
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:Jungseog Kang
-
依托单位: